|
Tacrolimus is an immunosuppressant. Immunosuppressants decrease the effects of your body’s immune system. Tacrolimus is used to prevent your body from rejecting a liver or kidney transplant. It is usually combined with a steroid ...
|
health.yahoo.com/drug/d03752a1#d03752a1-whatis
health.yahoo.com/drug/d03752a1#d03752a1-whatis
|
|
|
|
Taking tacrolimus may increase your risk of developing certain types of cancer, especially skin cancer. The risk may be higher in people who are treated over long periods of time with drugs that weaken the immune system. ... tacrolimus Drug Interactions...
|
www.drugs.com/mtm/tacrolimus.html
www.drugs.com/mtm/tacrolimus.html
|
|
|
|
tacrolimus Oral, Intravenous (tacrolimus) patient information. Detailed drug information for the consumer, includes dosage, tacrolimus Oral, Intravenous side effects and more. ... Detailed Drug Information for the Consumer > tacrolimus Oral, Intravenous...
|
www.drugs.com/cons/tacrolimus-oral-intravenous.html
www.drugs.com/cons/tacrolimus-oral-intravenous.html
|
|
|
Learn about the prescription medication Prograf (Tacrolimus), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling. ... Although there is a lack of direct correlation between tacrolimus concentrations and drug efficacy, data from Phase II and III studies of liver transplant patients have shown...
|
www.rxlist.com/prograf-drug.htm
www.rxlist.com/prograf-drug.htm
|
|
Child-Pugh score ?10) appears to affect the metabolism of tacrolimus. The half-life of the drug was prolonged and the clearance reduced after I.V. administration. The bioavailability of tacrolimus was also increased after oral administration.
|
www.merck.com/mmpe/lexicomp/tacrolimus.html
www.merck.com/mmpe/lexicomp/tacrolimus.html
|
|
Nucleoside analogues or efavirenz lead to little change in tacrolimus pharmacokinetics, in contrast, nelfinavir and lopinavir/ritonavir cause a large inhibition of tacrolimus first pass effect and clearance, producing an important decrease in tacrolimus dosing. ... All patients received tacrolimus and prednisolone.
|
www.aegis.com/conferences/croi/2005/662.html
|
|
All Medscape eMedicine Drug Reference MEDLINE ... Tacrolimus [therapeutic use] ... 109581-93-3 (Tacrolimus)
|
www.medscape.com/medline/abstract/12431607
|
|
Determination of the Immunosuppressive Drug Tacrolimus in its. Dosage Forms by High-Performance Liquid Chromatography. Y. Namiki* / A. Fujiwara / N. Kihara ...
|
www.springerlink.com/index/T44V44V032382RM7.pdf
|
|
All Medscape eMedicine Drug Reference MEDLINE ... Therapeutic drug monitoring is important to avoid unnecessary toxicity, but the lower limit has not been fully defined. Clearly, many patients with < 5 ng/ml have excellent hepatic function. ... Tacrolimus [therapeutic use]
|
www.medscape.com/medline/abstract/8588228
|
|